2018-2023 Global Multiple Sclerosis Treatment Market Report (Status and Outlook)

October 2018 | 116 pages | ID: 2CA2338BAB8EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Multiple Sclerosis Treatment market for 2018-2023.

Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and sometimes psychiatric problems. Specific symptoms can include double vision, blindness in one eye, muscle weakness, trouble with sensation, or trouble with coordination. MS takes several forms, with new symptoms either occurring in isolated attacks (relapsing forms) or building up over time (progressive forms). Between attacks, symptoms may disappear completely; however, permanent neurological problems often remain, especially as the disease advances.
Although there is no known cure for multiple sclerosis, several therapies have proven helpful. The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. Starting medications is generally recommended in people after the first attack when more than two lesions are seen on MRI.
Over the next five years, LPI(LP Information) projects that Multiple Sclerosis Treatment will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Multiple Sclerosis Treatment market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Immunomodulators
• Immunosuppressant

Segmentation by application:

• Veterinary Hospitals
• Veterinary Clinics
• Research Institutions

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Teva Pharmaceutical Industries
• Bayer
• Biogen Idec
• Pfizer
• Novartis

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Multiple Sclerosis Treatment market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Multiple Sclerosis Treatment market by identifying its various subsegments.
• Focuses on the key global Multiple Sclerosis Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Multiple Sclerosis Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Multiple Sclerosis Treatment submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Multiple Sclerosis Treatment Market Size 2013-2023
  2.1.2 Multiple Sclerosis Treatment Market Size CAGR by Region
2.2 Multiple Sclerosis Treatment Segment by Type
  2.2.1 Immunomodulators
  2.2.2 Immunosuppressant
2.3 Multiple Sclerosis Treatment Market Size by Type
  2.3.1 Global Multiple Sclerosis Treatment Market Size Market Share by Type (2013-2018)
  2.3.2 Global Multiple Sclerosis Treatment Market Size Growth Rate by Type (2013-2018)
2.4 Multiple Sclerosis Treatment Segment by Application
  2.4.1 Veterinary Hospitals
  2.4.2 Veterinary Clinics
  2.4.3 Research Institutions
2.5 Multiple Sclerosis Treatment Market Size by Application
  2.5.1 Global Multiple Sclerosis Treatment Market Size Market Share by Application (2013-2018)
  2.5.2 Global Multiple Sclerosis Treatment Market Size Growth Rate by Application (2013-2018)

3 GLOBAL MULTIPLE SCLEROSIS TREATMENT BY PLAYERS

3.1 Global Multiple Sclerosis Treatment Market Size Market Share by Players
  3.1.1 Global Multiple Sclerosis Treatment Market Size by Players (2016-2018)
  3.1.2 Global Multiple Sclerosis Treatment Market Size Market Share by Players (2016-2018)
3.2 Global Multiple Sclerosis Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 MULTIPLE SCLEROSIS TREATMENT BY REGIONS

4.1 Multiple Sclerosis Treatment Market Size by Regions
4.2 Americas Multiple Sclerosis Treatment Market Size Growth
4.3 APAC Multiple Sclerosis Treatment Market Size Growth
4.4 Europe Multiple Sclerosis Treatment Market Size Growth
4.5 Middle East & Africa Multiple Sclerosis Treatment Market Size Growth

5 AMERICAS

5.1 Americas Multiple Sclerosis Treatment Market Size by Countries
5.2 Americas Multiple Sclerosis Treatment Market Size by Type
5.3 Americas Multiple Sclerosis Treatment Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Multiple Sclerosis Treatment Market Size by Countries
6.2 APAC Multiple Sclerosis Treatment Market Size by Type
6.3 APAC Multiple Sclerosis Treatment Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Multiple Sclerosis Treatment by Countries
7.2 Europe Multiple Sclerosis Treatment Market Size by Type
7.3 Europe Multiple Sclerosis Treatment Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Multiple Sclerosis Treatment by Countries
8.2 Middle East & Africa Multiple Sclerosis Treatment Market Size by Type
8.3 Middle East & Africa Multiple Sclerosis Treatment Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL MULTIPLE SCLEROSIS TREATMENT MARKET FORECAST

10.1 Global Multiple Sclerosis Treatment Market Size Forecast (2018-2023)
10.2 Global Multiple Sclerosis Treatment Forecast by Regions
  10.2.1 Global Multiple Sclerosis Treatment Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Multiple Sclerosis Treatment Forecast by Type
10.8 Global Multiple Sclerosis Treatment Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Teva Pharmaceutical Industries
  11.1.1 Company Details
  11.1.2 Multiple Sclerosis Treatment Product Offered
  11.1.3 Teva Pharmaceutical Industries Multiple Sclerosis Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Teva Pharmaceutical Industries News
11.2 Bayer
  11.2.1 Company Details
  11.2.2 Multiple Sclerosis Treatment Product Offered
  11.2.3 Bayer Multiple Sclerosis Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Bayer News
11.3 Biogen Idec
  11.3.1 Company Details
  11.3.2 Multiple Sclerosis Treatment Product Offered
  11.3.3 Biogen Idec Multiple Sclerosis Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Biogen Idec News
11.4 Pfizer
  11.4.1 Company Details
  11.4.2 Multiple Sclerosis Treatment Product Offered
  11.4.3 Pfizer Multiple Sclerosis Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Pfizer News
11.5 Novartis
  11.5.1 Company Details
  11.5.2 Multiple Sclerosis Treatment Product Offered
  11.5.3 Novartis Multiple Sclerosis Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Novartis News

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Multiple Sclerosis Treatment
Figure Multiple Sclerosis Treatment Report Years Considered
Figure Market Research Methodology
Figure Global Multiple Sclerosis Treatment Market Size Growth Rate 2013-2023 ($ Millions)
Table Multiple Sclerosis Treatment Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Immunomodulators
Table Major Players of Immunosuppressant
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Multiple Sclerosis Treatment Market Size Market Share by Type (2013-2018)
Figure Global Multiple Sclerosis Treatment Market Size Market Share by Type (2013-2018)
Figure Global Immunomodulators Market Size Growth Rate
Figure Global Immunosuppressant Market Size Growth Rate
Figure Multiple Sclerosis Treatment Consumed in Veterinary Hospitals
Figure Global Multiple Sclerosis Treatment Market: Veterinary Hospitals (2013-2018) ($ Millions)
Figure Global Veterinary Hospitals YoY Growth ($ Millions)
Figure Multiple Sclerosis Treatment Consumed in Veterinary Clinics
Figure Global Multiple Sclerosis Treatment Market: Veterinary Clinics (2013-2018) ($ Millions)
Figure Global Veterinary Clinics YoY Growth ($ Millions)
Figure Multiple Sclerosis Treatment Consumed in Research Institutions
Figure Global Multiple Sclerosis Treatment Market: Research Institutions (2013-2018) ($ Millions)
Figure Global Research Institutions YoY Growth ($ Millions)
Table Global Multiple Sclerosis Treatment Market Size by Application (2013-2018) ($ Millions)
Table Global Multiple Sclerosis Treatment Market Size Market Share by Application (2013-2018)
Figure Global Multiple Sclerosis Treatment Market Size Market Share by Application (2013-2018)
Figure Global Multiple Sclerosis Treatment Market Size in Veterinary Hospitals Growth Rate
Figure Global Multiple Sclerosis Treatment Market Size in Veterinary Clinics Growth Rate
Figure Global Multiple Sclerosis Treatment Market Size in Research Institutions Growth Rate
Table Global Multiple Sclerosis Treatment Revenue by Players (2016-2018) ($ Millions)
Table Global Multiple Sclerosis Treatment Revenue Market Share by Players (2016-2018)
Figure Global Multiple Sclerosis Treatment Revenue Market Share by Players in 2017
Table Global Multiple Sclerosis Treatment Key Players Head office and Products Offered
Table Multiple Sclerosis Treatment Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Multiple Sclerosis Treatment Market Size by Regions 2013-2018 ($ Millions)
Table Global Multiple Sclerosis Treatment Market Size Market Share by Regions 2013-2018
Figure Global Multiple Sclerosis Treatment Market Size Market Share by Regions 2013-2018
Figure Americas Multiple Sclerosis Treatment Market Size 2013-2018 ($ Millions)
Figure APAC Multiple Sclerosis Treatment Market Size 2013-2018 ($ Millions)
Figure Europe Multiple Sclerosis Treatment Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Multiple Sclerosis Treatment Market Size 2013-2018 ($ Millions)
Table Americas Multiple Sclerosis Treatment Market Size by Countries (2013-2018) ($ Millions)
Table Americas Multiple Sclerosis Treatment Market Size Market Share by Countries (2013-2018)
Figure Americas Multiple Sclerosis Treatment Market Size Market Share by Countries in 2017
Table Americas Multiple Sclerosis Treatment Market Size by Type (2013-2018) ($ Millions)
Table Americas Multiple Sclerosis Treatment Market Size Market Share by Type (2013-2018)
Figure Americas Multiple Sclerosis Treatment Market Size Market Share by Type in 2017
Table Americas Multiple Sclerosis Treatment Market Size by Application (2013-2018) ($ Millions)
Table Americas Multiple Sclerosis Treatment Market Size Market Share by Application (2013-2018)
Figure Americas Multiple Sclerosis Treatment Market Size Market Share by Application in 2017
Figure United States Multiple Sclerosis Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Canada Multiple Sclerosis Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Multiple Sclerosis Treatment Market Size Growth 2013-2018 ($ Millions)
Table APAC Multiple Sclerosis Treatment Market Size by Countries (2013-2018) ($ Millions)
Table APAC Multiple Sclerosis Treatment Market Size Market Share by Countries (2013-2018)
Figure APAC Multiple Sclerosis Treatment Market Size Market Share by Countries in 2017
Table APAC Multiple Sclerosis Treatment Market Size by Type (2013-2018) ($ Millions)
Table APAC Multiple Sclerosis Treatment Market Size Market Share by Type (2013-2018)
Figure APAC Multiple Sclerosis Treatment Market Size Market Share by Type in 2017
Table APAC Multiple Sclerosis Treatment Market Size by Application (2013-2018) ($ Millions)
Table APAC Multiple Sclerosis Treatment Market Size Market Share by Application (2013-2018)
Figure APAC Multiple Sclerosis Treatment Market Size Market Share by Application in 2017
Figure China Multiple Sclerosis Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Japan Multiple Sclerosis Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Korea Multiple Sclerosis Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Multiple Sclerosis Treatment Market Size Growth 2013-2018 ($ Millions)
Figure India Multiple Sclerosis Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Australia Multiple Sclerosis Treatment Market Size Growth 2013-2018 ($ Millions)
Table Europe Multiple Sclerosis Treatment Market Size by Countries (2013-2018) ($ Millions)
Table Europe Multiple Sclerosis Treatment Market Size Market Share by Countries (2013-2018)
Figure Europe Multiple Sclerosis Treatment Market Size Market Share by Countries in 2017
Table Europe Multiple Sclerosis Treatment Market Size by Type (2013-2018) ($ Millions)
Table Europe Multiple Sclerosis Treatment Market Size Market Share by Type (2013-2018)
Figure Europe Multiple Sclerosis Treatment Market Size Market Share by Type in 2017
Table Europe Multiple Sclerosis Treatment Market Size by Application (2013-2018) ($ Millions)
Table Europe Multiple Sclerosis Treatment Market Size Market Share by Application (2013-2018)
Figure Europe Multiple Sclerosis Treatment Market Size Market Share by Application in 2017
Figure Germany Multiple Sclerosis Treatment Market Size Growth 2013-2018 ($ Millions)
Figure France Multiple Sclerosis Treatment Market Size Growth 2013-2018 ($ Millions)
Figure UK Multiple Sclerosis Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Italy Multiple Sclerosis Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Russia Multiple Sclerosis Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Spain Multiple Sclerosis Treatment Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Multiple Sclerosis Treatment Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Multiple Sclerosis Treatment Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Multiple Sclerosis Treatment Market Size Market Share by Countries in 2017
Table Middle East & Africa Multiple Sclerosis Treatment Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Multiple Sclerosis Treatment Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Multiple Sclerosis Treatment Market Size Market Share by Type in 2017
Table Middle East & Africa Multiple Sclerosis Treatment Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Multiple Sclerosis Treatment Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Multiple Sclerosis Treatment Market Size Market Share by Application in 2017
Figure Egypt Multiple Sclerosis Treatment Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Multiple Sclerosis Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Israel Multiple Sclerosis Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Multiple Sclerosis Treatment Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Multiple Sclerosis Treatment Market Size Growth 2013-2018 ($ Millions)
Figure Global Multiple Sclerosis Treatment arket Size Forecast (2018-2023) ($ Millions)
Table Global Multiple Sclerosis Treatment Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Multiple Sclerosis Treatment Market Size Market Share Forecast by Regions
Figure Americas Multiple Sclerosis Treatment Market Size 2018-2023 ($ Millions)
Figure APAC Multiple Sclerosis Treatment Market Size 2018-2023 ($ Millions)
Figure Europe Multiple Sclerosis Treatment Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Multiple Sclerosis Treatment Market Size 2018-2023 ($ Millions)
Figure United States Multiple Sclerosis Treatment Market Size 2018-2023 ($ Millions)
Figure Canada Multiple Sclerosis Treatment Market Size 2018-2023 ($ Millions)
Figure Mexico Multiple Sclerosis Treatment Market Size 2018-2023 ($ Millions)
Figure Brazil Multiple Sclerosis Treatment Market Size 2018-2023 ($ Millions)
Figure China Multiple Sclerosis Treatment Market Size 2018-2023 ($ Millions)
Figure Japan Multiple Sclerosis Treatment Market Size 2018-2023 ($ Millions)
Figure Korea Multiple Sclerosis Treatment Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Multiple Sclerosis Treatment Market Size 2018-2023 ($ Millions)
Figure India Multiple Sclerosis Treatment Market Size 2018-2023 ($ Millions)
Figure Australia Multiple Sclerosis Treatment Market Size 2018-2023 ($ Millions)
Figure Germany Multiple Sclerosis Treatment Market Size 2018-2023 ($ Millions)
Figure France Multiple Sclerosis Treatment Market Size 2018-2023 ($ Millions)
Figure UK Multiple Sclerosis Treatment Market Size 2018-2023 ($ Millions)
Figure Italy Multiple Sclerosis Treatment Market Size 2018-2023 ($ Millions)
Figure Russia Multiple Sclerosis Treatment Market Size 2018-2023 ($ Millions)
Figure Spain Multiple Sclerosis Treatment Market Size 2018-2023 ($ Millions)
Figure Egypt Multiple Sclerosis Treatment Market Size 2018-2023 ($ Millions)
Figure South Africa Multiple Sclerosis Treatment Market Size 2018-2023 ($ Millions)
Figure Israel Multiple Sclerosis Treatment Market Size 2018-2023 ($ Millions)
Figure Turkey Multiple Sclerosis Treatment Market Size 2018-2023 ($ Millions)
Figure GCC Countries Multiple Sclerosis Treatment Market Size 2018-2023 ($ Millions)
Table Global Multiple Sclerosis Treatment Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Multiple Sclerosis Treatment Market Size Market Share Forecast by Type (2018-2023)
Table Global Multiple Sclerosis Treatment Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Multiple Sclerosis Treatment Market Size Market Share Forecast by Application (2018-2023)
Table Teva Pharmaceutical Industries Basic Information, Head Office, Major Market Areas and Its Competitors
Table Teva Pharmaceutical Industries Multiple Sclerosis Treatment Revenue and Gross Margin (2016-2018)
Figure Teva Pharmaceutical Industries Multiple Sclerosis Treatment Market Share (2016-2018)
Table Bayer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bayer Multiple Sclerosis Treatment Revenue and Gross Margin (2016-2018)
Figure Bayer Multiple Sclerosis Treatment Market Share (2016-2018)
Table Biogen Idec Basic Information, Head Office, Major Market Areas and Its Competitors
Table Biogen Idec Multiple Sclerosis Treatment Revenue and Gross Margin (2016-2018)
Figure Biogen Idec Multiple Sclerosis Treatment Market Share (2016-2018)
Table Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pfizer Multiple Sclerosis Treatment Revenue and Gross Margin (2016-2018)
Figure Pfizer Multiple Sclerosis Treatment Market Share (2016-2018)
Table Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novartis Multiple Sclerosis Treatment Revenue and Gross Margin (2016-2018)
Figure Novartis Multiple Sclerosis Treatment Market Share (2016-2018)